Recommendations for the management of autoinflammatory diseases

@article{terHaar2015RecommendationsFT,
  title={Recommendations for the management of autoinflammatory diseases},
  author={Nienke M. ter Haar and Marlen Oswald and Jerold Jeyaratnam and Jordi Ant{\'o}n and Karyl S. Barron and Paul A Brogan and Luca Cantarini and Caroline Galeotti and Gilles Grateau and Veronique Hentgen and Micha{\"e}l F. Hofer and Tilmann Kallinich and Isabelle Kon{\'e}-Paut and Helen Jane Lachmann and Huri Ozdogan and Seza Ozen and Ricardo A. Russo and Anna Katharina Simon and Yosef Uziel and Carine Wouters and Brian M. Feldman and Sebastiaan Vastert and Nico M Wulffraat and Susanne M. Benseler and Joost Frenkel and Marco Gattorno and Jasmin Beate Kuemmerle-Deschner},
  journal={Annals of the Rheumatic Diseases},
  year={2015},
  volume={74},
  pages={1636 - 1644}
}
Autoinflammatory diseases are characterised by fever and systemic inflammation, with potentially serious complications. Owing to the rarity of these diseases, evidence-based guidelines are lacking. In 2012, the European project Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate regimens for the management of children and young adults with rheumatic diseases, facilitating the clinical practice of paediatricians and (paediatric… 
European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative
TLDR
These Single Hub and Access point for paediatric Rheumatology in Europe recommendations were formulated through an evidence-based consensus process to support uniform, high-quality standard of care for children with rare forms of paediatric systemic vasculitis.
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative
TLDR
The SHARE recommendations for cSLE and neuropsychiatric manifestations of cSle have been formulated by an evidence-based consensus process to support uniform, high-quality standards of care for children with cSLET.
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative
TLDR
Evidence-based recommendations were developed using the European League Against Rheumatism standard operating procedure and it was agreed that new classification criteria for paediatric APS are necessary, and APS in association with childhood-onset systemic lupus erythematosus should be identified by performing antiphospholipid antibody screening.
Autoinflammatory Diseases with Periodic Fevers
TLDR
Familial Mediterranean fever, cryopyrin-associated periodic syndrome (CAPS), tumor necrosis factor receptor- associated periodic fever syndrome (TRAPS), and hyperimmunoglobulinemia D and periodic fever Syndrome/mevalonate kinase deficiency (HIDS/MVKD) are the more common autoinflammatory diseases that are characterized by periodic fevers and attacks of inflammation.
European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative
TLDR
The Single Hub and Access point for paediatric Rheumatology in Europe initiative provides international evidence-based recommendations for diagnosing and treating Kawasaki disease in children, facilitating improvement and uniformity of care.
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative
TLDR
Evidence-based recommendations for diagnosis and treatment of childhood lupus nephritis have been generated to support uniform and high-quality care for all children with SLE.
Monogenic auto-inflammatory diseases in children and adults: what a rheumatologist should know
The article presents information on the current state of the problem of autoinflammatory diseases (AID) in rheumatology, reflects the clinical and demographic, laboratory and molecular genetic
OP-BRHE180325 656..671 ++
TLDR
These Single Hub and Access point for paediatric Rheumatology in Europe recommendations were formulated through an evidence-based consensus process to support uniform, high-quality standard of care for children with rare forms of paediatric systemic vasculitis.
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
TLDR
The SHARE initiative provides international, evidence-based recommendations for the diagnosis and treatment of IgAV that will facilitate improvement and uniformity of care.
Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative
TLDR
The PRO-KIND CAPS/TRAPS/MKD/HIDS working group established the first evidence-based, actionable treat-to-target consensus treatment plans for three rare hereditary autoinflammatory diseases, which will decrease variation in care and optimize health outcomes for children with AID.
...
...

References

SHOWING 1-10 OF 113 REFERENCES
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review
TLDR
Evaluating the response to treatment of autoinflammatory diseases from an international registry and an up-to-date literature review found that colchicine is the treatment of choice for FMF and IL-1 blockade for DIRA and CAPS and Corticosteroids on demand probably represent a valid therapeutic strategy for PFAPA, but also for MKD and TRAPS.
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
TLDR
Ten key recommendations for the management of systemic GC-therapy were formulated using a combination of systematically retrieved research evidence and expert consensus.
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
TLDR
More research is needed on the safety and immunogenicity of (live-attenuated) vaccination in PaedRD, particularly in those using biologicals, and the effect of vaccination on prevention of infections.
A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference
TLDR
Preliminary activity scores were obtained to measure disease activity in four main SAIDs using widely recognised consensus formation techniques and were developed for the purpose of clinical studies but could be used in clinical practice.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
TLDR
The 2010 European League against Rheumatism recommendations for the management of rheumatoid arthritis (RA) with synthetic and biological disease-modifying antirheumatic drugs (sDMARDs and b DMARDs, respectively) have been updated and are intended to improve outcome in patients with RA.
Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers
TLDR
Evidence-based provisional clinical criteria with high sensitivity and specificity for the clinical classification of patients with inherited periodic fevers have been developed and validated.
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
TLDR
Recommendations for vaccination in patients with AIIRD based on the currently available evidence and expert opinion were formulated, and more research is needed, particularly regarding the incidence of vaccine-preventable infectious diseases and the safety of vaccination in Patients with A IIRD.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
TLDR
Recommendations are intended to inform rheumatologists, patients and other stakeholders about a European consensus on the management of RA with DMARDs and GCs as well as strategies to reach optimal outcomes of RA based on evidence and expert opinion.
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry
TLDR
The largest reported case series to date, the genetic heterogeneity of TRAPS is accompanied by a variable phenotype at presentation, with little evidence of a significant effect of age or genotype on disease features at presentation.
Analysis of cryopyrin-associated periodic syndromes (CAPS) in German children: epidemiological, clinical and genetic characteristics.
TLDR
The aims were to determine the incidence of Cryopyrin-associated periodic syndromes and the spectrum of mutations in the NLRP3 (formerly= CIAS1) gene and to describe the clinical manifestations.
...
...